NEQA为新英国部门设定了舞台

分子诊断产品制造商Hibergene Diagnostics将直接向英国和爱尔兰的医疗保健提供者提供服务点（POC）和近科测试解决方案。

the Dublin-based company’s test solutions which cover infectious and transmissible disease areas - including respiratory, sexually transmitted infections, hospital acquired infections and women’s health – have been designed for improved turnaround in result times in almost any setting, bringing cost and time savings along with improved patient management.

Complementing the opening of its UK division, HiberGene were sponsors of UK NEQAS’ multi-disciplinary event ‘Supporting your point of care testing (POCT) service’ held at the Hyatt Regency Hotel in Birmingham on June 30, 2022. At the one-day seminar the company took part in key discussions on accrediting and implementing these services in a healthcare setting and the benefits that this can bring for both patients and clinicians.

Hibergene的David Corr首席执行官说：“在爱尔兰取得了巨大的成功之后，我们很高兴宣布我们的新专门的英国团队的推出，增强了我们为不断增长的客户群提供的地理覆盖范围和能力。我们的多学科团队拥有深厚的技术知识，这些知识在各种测试选项上，为每个客户提供最佳解决方案，以展示他们在英国NEQAS活动的主要讨论中展示他们的知识。”

更多信息在线的